SymbioCellTech, LLC Email Format

Biotechnology ResearchUtah, United States2-10 Employees

SymbioCellTech, LLC is a early-stage biotechnology company focused on cell-based therapies for diabetes. Its lead approach combines pancreatic islet cells with mesenchymal stem cells to form what it calls Neo-Islets, with the goal of restoring the body's own insulin production and achieving glucose control comparable to non-diabetic individuals. The company describes its therapy as suitable for outpatient administration, and it is pursuing clinical development for Type-1 Diabetes with plans to extend toward Type-2 Diabetes, alongside ongoing work in companion animal models under regulatory programs.

Based in Salt Lake City, Utah, SymbioCellTech operates within the biotechnology research sector and is identified as a university spin-out. The organization emphasizes pre-clinical data and progress toward regulatory submissions to enable human clinical trials, while also noting independent veterinary studies under the FDA’s INAD program and canine trials with favorable outcomes. Recent activity highlighted includes recognition at scientific and innovation events related to its NeoIslets approach.

Get verified SymbioCellTech, LLC emails free

Company overview Employee directory